Stay updated on Etrasimod in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.

Latest updates to the Etrasimod in Ulcerative Colitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new 'No longer looking for participants' note indicates enrollment has ceased, and additional help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') have been added. The page’s heading formatting for 'Intervention/Treatment' was updated and the revision version advanced from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page's revision metadata was updated from v3.5.4 to v3.5.5. This reflects a minor behind-the-scenes update to the page template or CMS, with no changes to study content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study document revision label was updated from v3.5.3 to v3.5.4, indicating an updated version of the protocol-related materials.SummaryDifference0.0%

- Check64 days agoChange Detected- Updates the citation entry for a specific PubMed-derived publication about non-serious adverse events in ulcerative colitis patients receiving etrasimod. - Updates the ClinicalTrials.gov page revision/build label from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check114 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Etrasimod in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.